Bruxellis Aprilis III, MMXXIV - Europaeae Unionis Commission nuntiatum est Release of Orff (EU) 2024/996, emendator EU Cosmetics Regulantur (EC) 1223/2009. Hoc regulatory update brings significant mutationes ad stibio industria in Europaeae unionem. Hic sunt clavis ornare ipsum:
Ban in IV-methylbenzylidene cjphor (IV Mbc)
Satus a May I, MMXXV, stibio continet IV-MBC erit prohibitus ab intrantes EU foro. Ceterum a Maii I, MMXXVI, in sale of stibio continet IV MBC erit prohibitus in EU foro.
Insuper de restricted ingredients
Pluribus ingredientia erit nuper restringitur, comprehendo alpha, Arbutin (*), Arbutin (*), Genristin (*), Daidzein (*), Kojic Acidum (*), Retinol (**), retiny (**).
(*) Februarii a I, MMXXV, stibio continet hae substantias, quae non occurrit certa conditionibus erit prohibitus ab intrantes EU foro. Praeterea, ex November I, MMXXV, in sale of stibio continet hae substantias, quae non occurrit ad certa condiciones erit prohibitus in EU foro.
(**) a November I, MMXXV, stibio continet hae substantias, quae non occurrit ad certa conditionibus erit prohibitus a intrantes EU foro. Ceterum a Maii I, MMXXVII, in venditionis de stibio continet hae substantias, quae non occurrit certa condiciones et prohibitus in EU forum.
Recognoscitur Requirements ad Triclocarban et Triclosan
Cosmetics containing these substances, if they meet the applicable conditions by April 23, 2024, can continue to be marketed within the EU until December 31, 2024. If these cosmetics have already been placed on the market by that date, they can be sold within the EU until October 31, 2025.
Remotionem de Requirements ad IV-methylbenzylidene Camphor
In requisitis ad usum IV-methylbenzylidene caphura fuisse delevit a Appendice VI (List of permittitur sunscreen agentibus pro stibio). Hoc Emendatione erit effective a Maii I, MMXXV.
UniProma propinqua Monitor Global regulatory mutationes et committitur providente nostra customers cum summa qualitas rudis materiae, quae plene obsequium et tutum.
Post tempus: Apr 10-2024